Respiratory Acidosis: Low Arterial Blood pH with Increased Arterial pCO2 and Arterial H2CO3- Increased
Neuromuscular disorders that decrease breathing, as produced by brain stem injury, myasthenia gravis, and poliomyelitis
If sufficiently severe, multiple non-neuromuscular causes of impaired ventilation, perfusion, or gas diffusion produced by embolism, infection, selected cancers, asthma, bronchitis, and emphysema.
Suggested Additional Lab Testing
Serial blood gases to assess arterial pH, arterial pco2 and arterial h2co3 are important to determine the severity and progression of disorders producing respiratory acidosis.
Any neuromuscular disorder or non-neuromuscular disorder leading to respiratory acidosis must be specifically identified from clinical signs and symptoms and other diagnostic tests.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Aspirin and Colorectal Cancer
- Study Reveals Scope of Genomic Variation Within Cancer Cell Lines
- IL-23 Drives Castration-Resistant Prostate Cancer
- Religion, Spirituality, May Influence Physical Health Outcomes in Survivors of Breast Cancer
- Immediate Instillation of Mitomycin C Post-TURBT May Benefit All Patients with Bladder Cancer
- FDA Grants Accelerated Approval to Nivolumab for Small Cell Lung Cancer
- Accelerated Intensity-Modulated Radiotherapy May Improve Outcomes in Localized Lung Cancer
- FDA Grants Approval to Lenvatinib as First-Line Therapy for Hepatocellular Carcinoma
- COPD May Not Affect Survival in Patients With Small Cell Lung Cancer
- Prescription Drug Coverage in Medicare Part D Is Tied to a Survival Advantage in Myeloma